Phibro Animal Health Corporation - Class A Common Stock (PAHC)
Healthcare › Pharmaceutical Preparations
Price History
Feb 9, 2026 — Apr 2, 2026Investment Snapshot
- Trading 191% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 6/9 — moderate financial health
- ROE of 23.5% — good return on equity
- Revenue growing at 27% annually
Phibro Animal Health Corporation - Class A Common Stock (PAHC) is a Healthcare company operating in Pharmaceutical Preparations, listed on the NASDAQ , with a market capitalisation of $2.2 billion . Key value metrics: P/E ratio 28.4, P/B ratio 6.68, Piotroski F-Score 6 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Phibro Animal Health Corporation - Class A Common Stock — Fundamental Analysis Summary
Phibro Animal Health Corporation - Class A Common Stock (PAHC) is currently trading 191% above its Graham Number of $18.85, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 28.4x.
On financial health, PAHC shows a moderate Piotroski F-Score of 6/9, and strong return on equity of 23.5% (sector average: -19.8%), and elevated leverage with a debt-to-equity ratio of 1.88.
StockPik's composite Value Score for PAHC is 74/100 — placing it in undervalued territory. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
PAHC reports a moderate gross margin of 32.9% (sector average: 33.5%) and a solid operating margin of 11.5%.
PAHC shows revenue growing at 27% year-over-year, with earnings growing at 1,898%.
PAHC pays a modest dividend yield of 0.9%.